Cancer Vaccines
Challenges and Opportunities in Translation (Translational Medicine)
1 edition
Our rough guess is there are 56,000 words in this book.
At a pace averaging 250 words per minute, this book will take 3 hours and 44 minutes to read. With a half hour per day, this will take 8 days to read.
How long will it take you?
This book will take an estimated to read at a reading speed averaging words per minute. With 30 minutes per day, this will take to read.
Enter your reading speedYou can take one of our WPM reading speed tests to find your reading speed.
Create a free account to track your reading progress, build your reading list, and set reading goals.
Author
Contributions
- Adrian Bot (Editor) - Contributor
- Mihail Obrocea (Editor) - Contributor
Publication
2008-04-02 - Informa Healthcare
Language
English
Word Count
56,000 words, Guess
Page Count
224 pages
Physical Format
Hardcover
Identifiers
- Internet Archivecancervaccinesch00bota
- Internet Archivecancervaccinesch0000unse
- ISBN-101420054678
- ISBN-139781420054675
- Library of Congress Control Number2007047354
and 3 more
- OCLC Control Number181903515
- Better World Books9781420054675
- Open LibraryOL11816667M
Classifications
- LCCRC271.I45C42 2008
- LCCRC271.I45 C42 2008
Description
"Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist. Cancer Vaccines: Challenges and Opportunities in Translation: critically analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential, discusses "theranostics" as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy, presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer and reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them"--Provided by publisher.
Subjects
Other Editions
- Cancer Vaccines: Challenges and Opportunities in Translation (Translational Medicine)
Reader Reviews
No reviews yet for this book.
Be the first to share your thoughts!